Introduction {#sec1}
============

Focal segmental glomerulosclerosis (FSGS) is a clinical pathological syndrome, and its typical pathological feature is sclerosing lesions in the focal glomeruli and in the glomerular segment. The clinical manifestations of FSGS patients are massive proteinuria, hematuria, hypertension, and progressive decrease in renal function. The condition of 3.6% of patients with end-stage renal disease developed from FSGS \[[@B1],[@B2]\]. Currently, the main clinical therapies for FSGS are immunologic drugs, glucocorticoids, and blockers of the renin--angiotensin system; however, their therapeutic effects are not satisfactory. \[[@B3]\]. Triptolide (TPL) is the most active and effective diterpene lactone epoxide compound isolated from Tripterygium. \[[@B4]\]. TPL has anti-inflammatory, anti-tumor, and immunologic effects on many diseases \[[@B4]\]. TPL inhibits the secretion of many cytokines, adhesion molecules, and chemokines and affects the functions of various cells, including dendritic cells and renal tubular epithelial cells \[[@B5],[@B6]\]. TPL has been reported to alleviate the progression of glomerulosclerosis and the excretion rate of urinary albumin to inhibit the progression of diabetic neuropathy \[[@B6]\]. However, the effects and mechanisms of TPL in FSGS are still unclear. We explored the mechanism of FSGS-mediated podocyte pathogenesis based on the FSGS rat model. The present study has great significance for the diagnosis, prevention, and treatment of FSGS.

In the past, research on Chinese herbal extracts focused on a particular aspect and on finding the biological characteristics explaining the pharmacological effect with respect to this aspect \[[@B7]\]; however, this approach is usually one-sided. It is important to explore the relation between the acquired proof and the research results. With the development of bioinformatics and network pharmacology, proposal of a theory and proving this theory through experiments has become the main method to explore the mechanism of Chinese herb compounds \[[@B8]\].

Network pharmacology is based on high-throughput omics data analysis, virtual computer computing and network database retrieval, and it combines systems biology with multidirectional pharmacology \[[@B9]\]. The mechanism of drug action was researched via the construction and analysis of biological networks. The systematic and holistic nature of network pharmacology is consistent with the characteristics of Chinese herbs, which exhibit multi-components, multi-targets, and systematic regulation. It has been widely used to explore the pharmacological basis of Chinese medicine and the drug mechanism and to interpret drug compatibility \[[@B10],[@B11]\]. Network pharmacology has been recognized by many Chinese medicine researchers \[[@B12]\]. The multi-component and multi-target network research mode breaks the traditional research mode of a single ingredient and a single target, providing a new method for comprehensive analysis of the mechanism of the compounds \[[@B13]\]. In the early stage, a total of 47 target genes and the corresponding 16 active constituents of Tripterygium were used to construct the ingredient-target network. The present study mainly explores the mechanism of TPL in FSGS through bioinformatics and functional experiments.

Materials and methods {#sec2}
=====================

Construction of the potential compound database for tripterygium {#sec2-1}
----------------------------------------------------------------

Using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (<http://lsp.nwu.edu.cn/tcmsp.php>, TCMSP), each candidate's drug ability was analyzed according to its oral bioavailability (OB) and drug-likeness (DL) indices recommended by the TCMSP. OB refers to the degree and rate of drug absorption into the circulatory system, which is an important indicator for objectively evaluating the intrinsic quality of drugs. The higher the OB of the compound, the more likely it is to be developed for clinical application. DL is the sum of the pharmacokinetic properties and safety, which arises from the interactions among the physicochemical properties and structural factors, including solubility, permeability, and stability. It can be used to optimize compounds, analyze the results of drug activity, predict *in vivo* pharmacokinetics, direct structure modifications, etc. As the TCMSP recommends, molecules with OB ≥ 30% and DL ≥ 0.18 were considered to exhibit relatively better pharmacological properties and were screened out as candidate compounds for further analysis.

Construction of the disease--target--compound network {#sec2-2}
-----------------------------------------------------

To comprehensively understand the molecular mechanisms, disease--compound--target networks were constructed using the Cytoscape visualization software 3.7.1. All target genes related to FSGC were obtained from the GeneCards database (<https://www.genecards.org/>). All the candidate compounds of Tripterygium were retrieved from the TCMSP to obtain the associated targets. Next, disease, compounds, and targets were inputted into the software, and a disease--compound--target interaction network was constructed. In the process of constructing the network, the layout algorithm (attribute circle layout) was applied. We can set the geometric position of every node and visually display the network topology using color, graphics, and symbols, making reasonable arrangements for every node and creating a clear visual effect. Degree and betweenness centrality are two important parameters of the topology structure, which were used to evaluate the essentiality of each target and compound.

PPI network construction and module analysis {#sec2-3}
--------------------------------------------

Search Tool for the Retrieval of Interacting Genes (STRING, <https://string-db.org>) is an online tool and used to construct the PPI network with confidence network edges and a medium confidence of 0.400 as the product criteria. Cytoscape 7.1.0 was used to perform the visualization of PPI network. The Molecular Complex Detection (MCODE) plug-in was used to screen the significant modules in the PPI network with a degree cut-off = 2, node score cut-off = 0.2, k-core = 2, and maximum depth = 100. The corresponding proteins in the central nodes and highly degree were potential core proteins encoded by key candidate genes that have important physiological regulatory functions.

GO terms and KEGG pathway enrichment analysis {#sec2-4}
---------------------------------------------

The Database for Annotation, Visualization, and Integrated Discovery (DAVID) database was used to perform GO enrichment analysis and KEGG pathway enrichment analysis. The GO terms were classified into three categories: biological process (BP), cellular component (CC); and molecular function (MF). *P*\<0.01 was considered to indicate a statistically significant difference.

Animals {#sec2-5}
-------

A total of 40 Sprague Dawley (SD) rats (male, weighing 160--180 g) were provided by Yison Bio co.LTD (Shanghai, China). Animals were housed individually in polycarbonate cages with wood chip bedding and were maintained in an air-conditioned animal room (temperature: 24°C, relative humidity: 55 ± 5%) on a 12-h light/dark cycle. Each animal experiment was carried out following the local Care for Laboratory Animals guidelines formulated by the Animal Experimental Center. The Ethics Committee had approved the studies using laboratory animals at the Guangxing Affiliated Hospital of Zhejiang Chinese Medical University.

FSGS model establishment {#sec2-6}
------------------------

All rats were randomly divided into a sham operation group (Sham), model group (FSGS), a group administered 80 mg/(kg·d) of Tripterygium by gavage (TPL(80)+FSGS), and a group administered 160 mg/(kg · d) of Tripterygium by gavage (TPL(160)+FSGS) (*n*=10 rats/group). One day before the operation, the TPL (80 or 160)+FSGS groups were administered TPL (Purifa Technology Development Co. Ltd., Chengdu, Sichuan, China) 80 or 160 mg/(kg d) by gavage; the Sham and FSGS groups were given isovolumic normal saline till the end of the experiment. The animals were intraperitoneally anesthetized with pentobarbital sodium (60 mg/kg body weight) and then placed on a homeothermic pad to maintain a core body temperature of 37°C to establish the FSGS model. The rats were first subjected to unilateral nephrectomy (left side) on day 1 and then injected in the caudal vein with adriamycin 5 mg/kg (on day 7) and adriamycin 3 mg/kg (on day 28) dissolved in 0.9% saline at a dilution of 2 mg/ml. Meanwhile, the kidneys of the control rats were exposed without dissecting the kidney tissue, followed by layer-by-layer suturing. These rats were then injected with saline on days 7 and 28 through the tail vein after the sham operation. Eight weeks post-surgery, blood samples were obtained from the tail veins, and the animals were killed. Following adequate anesthesia with pentobarbital sodium (180 mg/kg body weight), the organs were removed, frozen, or fixed in 4% paraformaldehyde. The serum and whole kidneys were harvested for biochemical, histological, and molecular analyses. The urinary protein levels of the rats were quantified before the end of the experiment. Animals with \>100 mg/24 h urinary protein indicated successful establishment of the model, and they were included in subsequent experiments.

Histological analyses {#sec2-7}
---------------------

The kidney tissues were fixed with 4% paraformaldehyde and embedded in paraffin. For histological analysis of lesions, 3 μm thick tissue sections were deparaffinized and stained with hematoxylin and eosin (HE) and periodic acid--Schiff (PAS). To calculate the degree of focal glomerular sclerosis, 40--60 glomeruli from each stained specimen were examined. The degree of sclerosis in each glomerulus was subjectively graded on a scale of 0--4 as follows: Grade 0, no change; Grade 1, sclerotic area less than or equal to 25% of the glomerulus or the presence of distinct adhesion between the capillary tuft and Bowman's capsule; Grade 2, sclerosis of 25--50% of the total glomerular area; Grade 3, sclerosis of 50--75% of the total glomerular area; and Grade 4, sclerosis of more than 75% of the glomerulus. The glomerular sclerosis index (GSI) was calculated using the following formula: $$\text{GSI} = (1 \times \text{N}1) + (2 \times \text{N}2) + (3 \times \text{N}3) + (4 \times \text{N}4)/(\text{N0} + \text{N}1 + \text{N}2 + \text{N}3 + \text{N}4)$$where *N* is the number of glomeruli for each grade of sclerosis.

Terminal dUTP nick-end labeling (TUNEL) staining {#sec2-8}
------------------------------------------------

An apoptosis detection kit (Promega, Madison, WI) was used to detect apoptosis according to a previously described method \[[@B14]\]. In brief, renal sections were subjected to TUNEL staining in accordance with the manufacturer's instructions. Later, IF microscopy was used to analyze the samples using a Zeiss Axiovert 200 M fluorescent microscope equipped with an AxioCamMR3 camera. Six fields (magnification 400×) were randomly selected from every section from 10 different rats, and cells with positive TUNEL staining were analyzed.

Glucose treatment and cell culture {#sec2-9}
----------------------------------

Rat glomerular podocytes were provided by Yubo Bio-Technique Co. Ltd (Shanghai, China), which were then cultivated according to a previously described method. Rat podocytes were cultivated in RPMI 1640 (Sigma-Aldrich, U.S.A.) containing streptomycin (100 μg/ml), penicillin (100 U/ml) (Solarbio, Beijing, China), and 10% fetal bovine serum (FBS, Gibco, NY, Grand Island). Subsequently, the cells were cultivated in a 5% CO~2~ incubator (Heraeus, Japan) at 33°C with interferon-γ (IFN-γ, 40 units/ml, Sigma, St Louis, MO, U.S.A.). Later, to induce differentiation, the podocytes were maintained at 37°C for 2 weeks in the absence of interferon. Podocytes (3 × 10^5^ cells/ml) were plated into 6-well plates in the presence of complete medium. After 24 h of standing, the podocytes were subjected to 24 and 48 h of TPL treatment at different concentrations (0, 5, 10, 20, 40, and 80 µmol/ml) before they were collected for subsequent analysis.

Transient transfection of plasmid DNA or siRNA {#sec2-10}
----------------------------------------------

The previously described human IL4 plasmid DNA at full length \[[@B15]\] was utilized to increase IL4 expression in cells via using transient transfection. pcDNA3.1-Myc/His EV plasmid (Life technologies) and On-Target Plus scramble RNA (Dharmacon) were used as transient transfection controls. Sequences for IL4 overexpression was ACAUUACUGCCUGAAGGGUGAAUUAACGC.

Counting Kit-8 (CCK-8) assay {#sec2-11}
----------------------------

Cells were grown into the 96-well plates at the density of 1 × 10^5^ cells/well, followed by 24 and 48 h of culture. Afterwards, cell viability was detected via using the CCK-8 kit (Dojindo Molecular Technologies, Gaithersburg, MD, U.S.A.). Then, cells in each group were cultivated for additional 24 and 48 h, respectively. Next, the CCK8 solution (10 μl) was added into cell at 37°C for 4 h. The absorbance was determined at 450 nm for obtaining the cell growth curve by the iMark microplate absorbance reader (Bio-Rad Laboratories, Inc., Hercules, CA, U.S.A.). Each experiment was carried out in triplicate.

Apoptosis detected by flow cytometry using Annexin V-FITC/PI staining {#sec2-12}
---------------------------------------------------------------------

Cell apoptosis was examined using the Annexin V-FITC/PI kit. Briefly, the cells were subjected to 0.25% trypsin digestion (Thermo Fisher Scientific, Waltham, MA, U.S.A.), followed by two washes with cold PBS; resuspension with 5 μl of PI, 5 μl of annexin V-FITC, and 500 μl of binding buffer; and incubation under 15 min of ambient temperature in the dark. Typically, Annexin V-FITC can bind to phosphatidylserine located on the outer apoptotic cell membrane, whereas PI can penetrate and stain cells with impaired membranes before binding to and labeling DNA. Data were collected using a flow cytometer (BD FACSCalibur; BD Biosciences, Franklin Lakes, NJ, U.S.A.) and analyzed by FlowJo. Clumped cells were excluded from the FSC-H/FSC-A dot plot for selecting the single cells. Cells in the annexin V-FITC-/PI+, annexin V-FITC+/PI+, and annexin V-FITC+/PI− quadrants were regarded as apoptotic cells.

Western blotting {#sec2-13}
----------------

Cells were subjected to lysis within the RIPA buffer (Beyotime, Shanghai, China) to collect the lysates in tubes, followed by 20 min of centrifugation at 4°C at 12,000 ***g***. Later, all supernatants were extracted, and protein content was measured by the BCA Protein Quantitative Kit (Beyotime, Shanghai, China). Then, Western blotting had been carried out in accordance with the instruction. Afterwards, 20 μg protein was subjected to 10% SDS-PAGE for separation, followed by transfer onto the PVDF membranes (Millipore, Billerica, MA, U.S.A.). Later, the membranes were blocked using 5% skimmed milk for 1 h, followed by overnight incubation with anti-IL-4 (dilution 1:8000, Abcam, Cambridge, MA, U.S.A., ab69811), nephrin (Abcam, ab227806; diluted at 1:1200), podocin (Abcam, ab50339; diluted at 1:1000), phosph (p)-Stat6 (BioVision, U.S.A., 3476-100; diluted at 1:1000), and GAPDH (Abcam, Cambridge, MA, U.S.A., ab181602; dilution 1:1000) rabbit anti-human antibodies, at 4°C, separately. Afterwards, cells were subjected to 1 h incubation with HRP-labeled secondary antibody (goat anti-rabbit antibody, Abcam, Cambridge, MA, U.S.A., ab116282; dilution 1:2000), prior to ECL detection. The Immobilon Western Chemiluminescent kit (WBKLS0100; Millipore, U.S.A.) was used to reveal the reactive bands using Roche Cobas e601 automated chemiluminescence image analysis system (Roche, U.S.A.).

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay {#sec2-14}
----------------------------------------------------------------------------

The GAPDH and IL-4 mRNA expression was detected through RT-qPCR. Total cellular RNA was isolated by TRIzol (Invitrogen, Carlsbad, CA, U.S.A.) in accordance with manufacturer protocols. Afterwards, cDNA was synthesized by reverse transcription of RNA according to the reactions below: RNase-free dH2O, total RNA (500 ng), and 5×PrimeScript RT Master Mix (2 μl) were added until the final volume became 10 μl. The Prism 7500 (ABI, Foster City, CA, U.S.A.) was employed for real-time PCR following the standard protocol of SYBR green assay. Primers used in the present study were shown below: IL-4-F: 5′-GATCACAAAGTACTGGTCCTGG-3′. Notably, GAPDH served as a normal control, with the primers of 5′-CACCCTGTTGCTGTAGCCAAA-3′ (reverse) and 5′-TGACTTCAACAGCGACACCCA-3′ (forward). Later, qPCR was carried out in triplicate using 7500 Real-Time PCR ABI system (ABI, U.S.A.) at a format of the 96-well plate. The reaction volume of 20 μl was prepared for PCR, which included forward primer (0.8 μl, 10 μM), RNase-free dH2O (7.4 μl),reverse primer (0.8 μl, 10 μM), 2×FastStart Universal SYBR Green Master (10 μl, ROX; Invitrogen, Guangzhou, China), and cDNA (1 μl). Besides, the PCR conditions were as follows, 10 min at 95°C, followed by 15 s at 95°C for 40 cycles, and 1 min at 60°C. The sequence detection software (1.6.3, Applied Biosystems, ABI, U.S.A.) was used for data analysis. Relative GAPDH or IL-4 mRNA level was measured and standardized according to 2^−ΔΔCt^ method based on GAPDH.

Statistical analyses {#sec2-15}
--------------------

SPSS 15.0 (<http://spss.en.softonic.com/>) was employed for all statistical analyses. Differences between two groups were analyzed through independent sample *t*-test, whereas those among several groups were examined by one-way analysis of variance (ANOVA). Rate was compared by chi-square test. The statistically significant level was set as *P*\<0.01 or *P*\<0.05.

Results {#sec3}
=======

Identification of active compounds in *Tripterygium wilfordii* {#sec3-1}
--------------------------------------------------------------

Using TCMSP databases (<http://lsp.nwsuaf.edu.cn/tcmsp.php>), 144 compounds of Tripterygium were retrieved. According to the criteria of DL ≥ 0.18 and OB ≥ 30%, a total of 51 chemical ingredients were selected ([Table 1](#T1){ref-type="table"}). TPL was verified as an active ingredient of *T. wilfordii*.

###### Information for 51 chemical ingredients of tripterygium

  --------------------------------------------------------------------------------------------------------------------
  Mol ID      Molecule name                                                                            OB (%)   DL
  ----------- ---------------------------------------------------------------------------------------- -------- ------
  MOL000211   Mairin                                                                                   55.38    0.78

  MOL000296   Hederagenin                                                                              36.91    0.75

  MOL000358   Beta-sitosterol                                                                          36.91    0.75

  MOL000422   Kaempferol                                                                               41.88    0.24

  MOL000449   Stigmasterol                                                                             43.83    0.76

  MOL002058   40957-99-1                                                                               57.2     0.62

  MOL003182   (+)-Medioresinol di-O-beta-D-glucopyranoside_qt                                          60.69    0.62

  MOL003184   81827-74-9                                                                               45.42    0.53

  MOL003185   (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a\                    48.84    0.38
              -dimethyl-4,9,10,10a-tetrahydro-3H-phenanthren-2-one                                              

  MOL003187   Triptolide                                                                               51.29    0.68

  MOL003188   Tripchlorolide                                                                           78.72    0.72

  MOL003189   WILFORLIDE A                                                                             35.66    0.72

  MOL003192   Triptonide                                                                               67.66    0.7

  MOL003196   Tryptophenolide                                                                          48.5     0.44

  MOL003198   5 alpha-Benzoyl-4 alpha-hydroxy-1 beta,8 alpha-dinicotinoyl-dihydro-agarofuran           35.26    0.72

  MOL003199   5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin                                 61.85    0.54

  MOL003206   Canin                                                                                    77.41    0.33

  MOL003208   Celafurine                                                                               72.94    0.44

  MOL003209   Celallocinnine                                                                           83.47    0.59

  MOL003210   Celapanine                                                                               30.18    0.82

  MOL003211   Celaxanthin                                                                              47.37    0.58

  MOL003217   Isoxanthohumol                                                                           56.81    0.39

  MOL003222   Salazinic acid                                                                           36.34    0.76

  MOL003224   Tripdiotolnide                                                                           56.4     0.67

  MOL003225   Hypodiolide A                                                                            76.13    0.49

  MOL003229   Triptinin B                                                                              34.73    0.32

  MOL003231   Triptoditerpenic acid B                                                                  40.02    0.36

  MOL003232   Triptofordin B1                                                                          39.55    0.84

  MOL003233   Triptofordin B2                                                                          107.71   0.76

  MOL003234   Triptofordin C2                                                                          30.16    0.76

  MOL003235   Triptofordin D1                                                                          32       0.75

  MOL003236   Triptofordin D2                                                                          30.38    0.69

  MOL003238   Triptofordin F1                                                                          33.91    0.6

  MOL003239   Triptofordin F2                                                                          33.62    0.67

  MOL003241   Triptofordin F4                                                                          31.37    0.67

  MOL003242   Triptofordinine A2                                                                       30.78    0.47

  MOL003244   Triptonide                                                                               68.45    0.68

  MOL003245   Triptonoditerpenic acid                                                                  42.56    0.39

  MOL003248   Triptonoterpene                                                                          48.57    0.28

  MOL003266   21-Hydroxy-30-norhopan-22-one                                                            34.11    0.77

  MOL003267   Wilformine                                                                               46.32    0.2

  MOL003278   Salaspermic acid                                                                         32.19    0.63

  MOL003279   99694-86-7                                                                               75.23    0.66

  MOL003280   TRIPTONOLIDE                                                                             49.51    0.49

  MOL003283   (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol         66.51    0.39

  MOL004443   Zhebeiresinol                                                                            58.72    0.19

  MOL005828   Nobiletin                                                                                61.67    0.52

  MOL007415   \[(2S)-2-\[\[(2S)-2-(benzoylamino)-3-phenylpropanoyl\]amino\]-3-phenylpropyl\] acetate   58.02    0.52

  MOL007535   (5S,8S,9S,10R,13R,14S,17R)-17-\[(1R,4R)-4-ethyl-1,5-dimethylhexyl\]\                     33.12    0.79
              -10,13-dimethyl-2,4,5,7,8,9,11,12,14,15,16,\                                                      
              17-dodecahydro-1H-cyclopenta\                                                                     
              \[a\]phenanthrene-3,6-dione                                                                       

  MOL009386   3,3′-bis-(3,4-dihydro-4-hydroxy-6-methoxy)-2H-1-benzopyran                               52.11    0.54

  MOL011169   Peroxyergosterol                                                                         44.39    0.82
  --------------------------------------------------------------------------------------------------------------------

Construction of the disease--target--compound network and PPI network {#sec3-2}
---------------------------------------------------------------------

The TCMSP and GeneCards databases were used to predict the potential targets for each compound in FSGS. As a result, 123 target genes from the GeneCards database were verified to be involved in FSGS ([Table 2](#T2){ref-type="table"}), and 695 target genes of Tripterygium from the TCMSP database were verified ([Table 3](#T3){ref-type="table"}). After importing data into Cytoscape, a disease--compound--target network was constructed ([Figure 1](#F1){ref-type="fig"}A). In addition, 47 overlapping target genes from two databases (TCMSP and GeneCards) were used to construct the PPI network. *IL4* obtained from the most significant module of the PPI network was verified as a key by using the MCODE plug-in of Cytoscape software, and it was found to be involved in FSGS ([Figure 1](#F1){ref-type="fig"}B--D).

![Disease--Compound--Target network and PPI network\
(**A**) The triptergium-target network of FSGS. (**B**) 47 overlapped target genes were from two databases (TCMSP and GeneCards). (**C**) 47 overlapped target genes were used to constructed PPI network and hub genes in PPI network. (**D**) Module and key gene were analysis and screened by using the MCODE plug-in Cytoscape software.](bsr-40-bsr20192920-g1){#F1}

###### Information for target genes of FSGS from GeneCards database

  Gene symbol    Description
  -------------- ---------------------------------------------------------------------------------------------------
  INF2           Inverted Formin, FH2 And WH2 Domain Containing
  TRPC6          Transient Receptor Potential Cation Channel Subfamily C Member 6
  CD2AP          CD2 Associated Protein
  ACTN4          Actinin Alpha 4
  NPHS1          NPHS1, Nephrin
  NPHS2          NPHS2, Podocin
  PAX2           Paired Box 2
  WT1            Wilms Tumor 1
  CRB2           Crumbs 2, Cell Polarity Complex Component
  MYO1E          Myosin IE
  APOL1          Apolipoprotein L1
  ANLN           Anillin Actin Binding Protein
  PLCE1          Phospholipase C Epsilon 1
  PTPRO          Protein Tyrosine Phosphatase, Receptor Type O
  NUP107         Nucleoporin 107
  ARHGAP24       Rho GTPase Activating Protein 24
  SMARCAL1       SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A Like 1
  COQ6           Coenzyme Q6, Monooxygenase
  LAMB2          Laminin Subunit Beta 2
  COL4A3         Collagen Type IV Alpha 3 Chain
  NUP93          Nucleoporin 93
  COQ8B          Coenzyme Q8B
  SYNPO          Synaptopodin
  TGFB1          Transforming Growth Factor Beta 1
  CLCN5          Chloride Voltage-Gated Channel 5
  MYH9           Myosin Heavy Chain 9
  LOC107985291   Uncharacterized LOC107985291
  COL4A4         Collagen Type IV Alpha 4 Chain
  SGPL1          Sphingosine-1-Phosphate Lyase 1
  NUP205         Nucleoporin 205
  PLAUR          Plasminogen Activator, Urokinase Receptor
  ACE            Angiotensin I Converting Enzyme
  COL4A5         Collagen Type IV Alpha 5 Chain
  CDKN1C         Cyclin Dependent Kinase Inhibitor 1C
  KIRREL2        Kirre Like Nephrin Family Adhesion Molecule 2
  CDKN1A         Cyclin Dependent Kinase Inhibitor 1A
  EMP2           Epithelial Membrane Protein 2
  CDKN1B         Cyclin Dependent Kinase Inhibitor 1B
  ILK            Integrin Linked Kinase
  CD80           CD80 Molecule
  SLC37A4        Solute Carrier Family 37 Member 4
  CTNNB1         Catenin Beta 1
  ITGA3          Integrin Subunit Alpha 3
  SCARB2         Scavenger Receptor Class B Member 2
  AGRN           Agrin
  ALG1           ALG1, Chitobiosyldiphosphodolichol Beta-Mannosyltransferase
  PLEKHH2        Pleckstrin Homology, MyTH4 And FERM Domain Containing H2
  MPV17          Mitochondrial Inner Membrane Protein MPV17
  ALB            Albumin
  WDR73          WD Repeat Domain 73
  REN            Renin
  NARS2          Asparaginyl-TRNA Synthetase 2, Mitochondrial
  SEC61A1        Sec61 Translocon Alpha 1 Subunit
  ZNF592         Zinc Finger Protein 592
  ITGB4          Integrin Subunit Beta 4
  IL1B           Interleukin 1 Beta
  OSGEP          O-Sialoglycoprotein Endopeptidase
  TP53RK         TP53 Regulating Kinase
  TPRKB          TP53RK Binding Protein
  LAGE3          L Antigen Family Member 3
  G6PC           Glucose-6-Phosphatase Catalytic Subunit
  VPS33A         VPS33A, CORVET/HOPS Core Subunit
  LPL            Lipoprotein Lipase
  ICAM1          Intercellular Adhesion Molecule 1
  CDH17          Cadherin 17
  MAGI2          Membrane Associated Guanylate Kinase, WW And PDZ Domain Containing 2
  ARHGDIA        Rho GDP Dissociation Inhibitor Alpha
  DNAI1          Dynein Axonemal Intermediate Chain 1
  ANKFY1         Ankyrin Repeat And FYVE Domain Containing 1
  BSND           Barttin CLCNK Type Accessory Beta Subunit
  MAX            MYC Associated Factor X
  FAH            Fumarylacetoacetate Hydrolase
  VHL            Von Hippel--Lindau Tumor Suppressor
  LYZ            Lysozyme
  AFP            Alpha Fetoprotein
  RET            Ret Proto-Oncogene
  MDH2           Malate Dehydrogenase 2
  SDHB           Succinate Dehydrogenase Complex Iron Sulfur Subunit B
  SDHA           Succinate Dehydrogenase Complex Flavoprotein Subunit A
  MUC1           Mucin 1, Cell Surface Associated
  FH             Fumarate Hydratase
  KIF1B          Kinesin Family Member 1B
  SDHC           Succinate Dehydrogenase Complex Subunit C
  SDHD           Succinate Dehydrogenase Complex Subunit D
  COQ2           Coenzyme Q2, Polyprenyltransferase
  PLEC           Plectin
  SDHAF2         Succinate Dehydrogenase Complex Assembly Factor 2
  TMEM127        Transmembrane Protein 127
  ELP1           Elongator Complex Protein 1
  ACHE           Acetylcholinesterase (Cartwright Blood Group)
  TJP1           Tight Junction Protein 1
  KIRREL1        Kirre Like Nephrin Family Adhesion Molecule 1
  NEDE           Nephropathy, Progressive, With Deafness
  PDGFA          Platelet Derived Growth Factor Subunit A
  CD40LG         CD40 Ligand
  ENTPD5         Ectonucleoside Triphosphate Diphosphohydrolase 5
  GAPVD1         GTPase Activating Protein And VPS9 Domains 1
  NUMBL          NUMB Like, Endocytic Adaptor Protein
  KANK2          KN Motif And Ankyrin Repeat Domains 2
  CD79A          CD79a Molecule
  BRAF           B-Raf Proto-Oncogene, Serine/Threonine Kinase
  NDN            Necdin, MAGE Family Member
  AXDND1         Axonemal Dynein Light Chain Domain Containing 1
  PLCE1-AS1      PLCE1 Antisense RNA 1
  LMX1B          LIM Homeobox Transcription Factor 1 Beta
  WT1-AS         WT1 Antisense RNA
  PODXL          Podocalyxin Like
  INS            Insulin
  VIM            Vimentin
  NAGLU          N-Acetyl-Alpha-Glucosaminidase
  ACTB           Actin Beta
  NR5A1          Nuclear Receptor Subfamily 5 Group A Member 1
  LOC105369403   Uncharacterized LOC105369403
  ITGB1          Integrin Subunit Beta 1
  UTRN           Utrophin
  ALG13          ALG13, UDP-N-Acetylglucosaminyltransferase Subunit
  CLDN1          Claudin 1
  CCN2           Cellular Communication Network Factor 2
  OCRL           OCRL, Inositol Polyphosphate-5-Phosphatase
  CMIP           C-Maf Inducing Protein
  ACTL7B         Actin Like 7B
  NXF5           Nuclear RNA Export Factor 5
  CUBN           Cubilin
  LCAT           Lecithin-Cholesterol Acyltransferase
  AGTR1          Angiotensin II Receptor Type 1
  LRP2           LDL Receptor Related Protein 2
  TNF            Tumor Necrosis Factor
  BAX            BCL2 Associated X, Apoptosis Regulator
  TLR4           Toll Like Receptor 4
  ITGB3          Integrin Subunit Beta 3
  DAG1           Dystroglycan 1
  CCL2           C-C Motif Chemokine Ligand 2
  NGF            Nerve Growth Factor
  CYCS           Cytochrome *C*, Somatic
  VTN            Vitronectin
  SMAD3          SMAD Family Member 3
  NOTCH1         Notch 1
  WNT1           Wnt Family Member 1
  CCNA2          Cyclin A2
  NTRK2          Neurotrophic Receptor Tyrosine Kinase 2
  DBH            Dopamine Beta-Hydroxylase
  SMARCA4        SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 4
  SMARCA2        SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 2
  IDS            Iduronate 2-Sulfatase
  PYGL           Glycogen Phosphorylase L
  GUSB           Glucuronidase Beta
  GALK1          Galactokinase 1
  APRT           Adenine Phosphoribosyltransferase
  ALAD           Aminolevulinate Dehydratase
  PAX6           Paired Box 6
  SOX9           SRY-Box 9
  CLCN7          Chloride Voltage-Gated Channel 7
  ALDOB          Aldolase, Fructose-Bisphosphate B
  HYAL1          Hyaluronidase 1
  PHKA2          Phosphorylase Kinase Regulatory Subunit Alpha 2
  HEXA           Hexosaminidase Subunit Alpha
  HPD            4-Hydroxyphenylpyruvate Dioxygenase
  ARSB           Arylsulfatase B
  APOC2          Apolipoprotein C2
  GALNS          Galactosamine (N-Acetyl)-6-Sulfatase
  CLCNKB         Chloride Voltage-Gated Channel Kb
  AMH            Anti-Mullerian Hormone
  GNS            Glucosamine (N-Acetyl)-6-Sulfatase
  SGSH           N-Sulfoglucosamine Sulfohydrolase
  FGF9           Fibroblast Growth Factor 9
  CLCN4          Chloride Voltage-Gated Channel 4
  IDUA           Iduronidase, Alpha-L-
  TIA1           TIA1 Cytotoxic Granule Associated RNA Binding Protein
  INPP5B         Inositol Polyphosphate-5-Phosphatase B
  CLCNKA         Chloride Voltage-Gated Channel Ka
  CLDN16         Claudin 16
  G6PC3          Glucose-6-Phosphatase Catalytic Subunit 3
  BAZ1A          Bromodomain Adjacent To Zinc Finger Domain 1A
  GSTZ1          Glutathione S-Transferase Zeta 1
  CIAO1          Cytosolic Iron-Sulfur Assembly Component 1
  ELP3           Elongator Acetyltransferase Complex Subunit 3
  SMARCA1        SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 1
  GABRE          Gamma-Aminobutyric Acid Type A Receptor Epsilon Subunit
  USP19          Ubiquitin Specific Peptidase 19
  ELP2           Elongator Acetyltransferase Complex Subunit 2
  TIMM8B         Translocase Of Inner Mitochondrial Membrane 8 Homolog B
  CPSF7          Cleavage And Polyadenylation Specific Factor 7
  ASTN1          Astrotactin 1
  LHX9           LIM Homeobox 9
  SRY            Sex Determining Region Y
  ZNF274         Zinc Finger Protein 274
  ARSH           Arylsulfatase Family Member H
  MFRP           Membrane Frizzled-Related Protein
  TECPR2         Tectonin Beta-Propeller Repeat Containing 2
  YIPF3          Yip1 Domain Family Member 3
  ZFY            Zinc Finger Protein Y-Linked
  FAM47E         Family With Sequence Similarity 47 Member E
  LOC100506321   Uncharacterized LOC100506321
  LAMB1          Laminin Subunit Beta 1
  PCNA           Proliferating Cell Nuclear Antigen
  MT-ND2         Mitochondrially Encoded NADH:Ubiquinone Oxidoreductase Core Subunit 2
  MT-CO1         Mitochondrially Encoded Cytochrome C Oxidase I
  MT-CO2         Mitochondrially Encoded Cytochrome C Oxidase II
  CTSL           Cathepsin L
  SERPINE1       Serpin Family E Member 1
  EZR            Ezrin
  IFI27          Interferon Alpha Inducible Protein 27
  AKT1           AKT Serine/Threonine Kinase 1
  CCND1          Cyclin D1
  BMP6           Bone Morphogenetic Protein 6
  LMNA           Lamin A/C
  CR1            Complement C3b/C4b Receptor 1 (Knops Blood Group)
  SMAD2          SMAD Family Member 2
  AGT            Angiotensinogen
  CLU            Clusterin
  CCNB1          Cyclin B1
  PPARG          Peroxisome Proliferator Activated Receptor Gamma
  TIMP2          TIMP Metallopeptidase Inhibitor 2
  IL6            Interleukin 6
  EDN1           Endothelin 1
  DNM1           Dynamin 1
  CDH2           Cadherin 2
  JAG1           Jagged 1
  MME            Membrane Metalloendopeptidase
  CAMK2B         Calcium/Calmodulin Dependent Protein Kinase II Beta
  FYN            FYN Proto-Oncogene, Src Family Tyrosine Kinase
  LRP5           LDL Receptor Related Protein 5
  PTK2           Protein Tyrosine Kinase 2
  LRP6           LDL Receptor Related Protein 6
  VCL            Vinculin
  ITGAV          Integrin Subunit Alpha V
  KRT8           Keratin 8
  PLCG1          Phospholipase C Gamma 1
  DKK1           Dickkopf WNT Signaling Pathway Inhibitor 1
  CD151          CD151 Molecule (Raph Blood Group)
  NCK1           NCK Adaptor Protein 1
  YWHAQ          Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Theta
  IRF6           Interferon Regulatory Factor 6
  PARVA          Parvin Alpha
  KIRREL3        Kirre Like Nephrin Family Adhesion Molecule 3
  MKI67          Marker Of Proliferation Ki-67
  LAMA5          Laminin Subunit Alpha 5
  TLN1           Talin 1
  LIMS1          LIM Zinc Finger Domain Containing 1
  FAT1           FAT Atypical Cadherin 1
  MIR4758        MicroRNA 4758
  MIR6852        MicroRNA 6852
  IL2            Interleukin 2
  PON1           Paraoxonase 1
  FN1            Fibronectin 1
  IL2RA          Interleukin 2 Receptor Subunit Alpha
  IL10           Interleukin 10
  NOS2           Nitric Oxide Synthase 2
  CABIN1         Calcineurin Binding Protein 1
  FGF2           Fibroblast Growth Factor 2
  LCN2           Lipocalin 2
  LAMC1          Laminin Subunit Gamma 1
  CDK2           Cyclin Dependent Kinase 2
  APOE           Apolipoprotein E
  PLA2G7         Phospholipase A2 Group VII
  HIF1A          Hypoxia Inducible Factor 1 Subunit Alpha
  PAFAH1B1       Platelet Activating Factor Acetylhydrolase 1b Regulatory Subunit 1
  F2R            Coagulation Factor II Thrombin Receptor
  GNA12          G Protein Subunit Alpha 12
  TTR            Transthyretin
  MMP14          Matrix Metallopeptidase 14
  ACTN1          Actinin Alpha 1
  ATP7A          ATPase Copper Transporting Alpha
  IGFBP3         Insulin Like Growth Factor Binding Protein 3
  ATP6AP2        ATPase H+ Transporting Accessory Protein 2
  GNE            Glucosamine (UDP-N-Acetyl)-2-Epimerase/N-Acetylmannosamine Kinase
  S100A4         S100 Calcium Binding Protein A4
  ENPEP          Glutamyl Aminopeptidase
  ZMPSTE24       Zinc Metallopeptidase STE24
  AMBP           Alpha-1-Microglobulin/Bikunin Precursor
  NPNT           Nephronectin
  CDK4           Cyclin Dependent Kinase 4
  PLAU           Plasminogen Activator, Urokinase
  RARA           Retinoic Acid Receptor Alpha
  MTHFR          Methylenetetrahydrofolate Reductase
  VLDLR          Very Low Density Lipoprotein Receptor
  CYP11B2        Cytochrome P450 Family 11 Subfamily B Member 2
  EYA1           EYA Transcriptional Coactivator And Phosphatase 1
  GPX3           Glutathione Peroxidase 3
  LTBP1          Latent Transforming Growth Factor Beta Binding Protein 1
  IGFBP1         Insulin Like Growth Factor Binding Protein 1
  PTPRU          Protein Tyrosine Phosphatase, Receptor Type U
  MAGI1          Membrane Associated Guanylate Kinase, WW And PDZ Domain Containing 1
  RAP1GAP        RAP1 GTPase Activating Protein
  NPHP4          Nephrocystin 4
  PDGFB          Platelet Derived Growth Factor Subunit B
  SLC12A1        Solute Carrier Family 12 Member 1
  FBXW7          F-Box And WD Repeat Domain Containing 7
  FABP1          Fatty Acid Binding Protein 1
  THBD           Thrombomodulin
  CLCF1          Cardiotrophin Like Cytokine Factor 1
  CHKA           Choline Kinase Alpha
  IFNA2          Interferon Alpha 2
  ECT2           Epithelial Cell Transforming 2
  COG2           Component Of Oligomeric Golgi Complex 2
  PDSS2          Decaprenyl Diphosphate Synthase Subunit 2
  FMN1           Formin 1
  SDK1           Sidekick Cell Adhesion Molecule 1
  MIR186         MicroRNA 186
  MIR193A        MicroRNA 193a
  MTOR           Mechanistic Target Of Rapamycin Kinase
  HMGCR          3-Hydroxy-3-Methylglutaryl-CoA Reductase
  MMP2           Matrix Metallopeptidase 2
  TGFBR1         Transforming Growth Factor Beta Receptor 1
  A2M            Alpha-2-Macroglobulin
  TFAM           Transcription Factor A, Mitochondrial
  NRF1           Nuclear Respiratory Factor 1
  IGFBP2         Insulin Like Growth Factor Binding Protein 2
  SMAD1          SMAD Family Member 1
  IGF1R          Insulin Like Growth Factor 1 Receptor
  IGF1           Insulin Like Growth Factor 1
  IRS1           Insulin Receptor Substrate 1
  SRC            SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase
  SLC2A1         Solute Carrier Family 2 Member 1
  APOC1          Apolipoprotein C1
  GAPDH          Glyceraldehyde-3-Phosphate Dehydrogenase
  GIPR           Gastric Inhibitory Polypeptide Receptor
  F2RL3          F2R Like Thrombin Or Trypsin Receptor 3
  DGKQ           Diacylglycerol Kinase Theta
  VEGFA          Vascular Endothelial Growth Factor A
  TIMP1          TIMP Metallopeptidase Inhibitor 1
  RHOA           Ras Homolog Family Member A
  MIF            Macrophage Migration Inhibitory Factor
  IL4            Interleukin 4
  MAPK14         Mitogen-Activated Protein Kinase 14
  DDIT3          DNA Damage Inducible Transcript 3
  RBP4           Retinol Binding Protein 4
  SP1            Sp1 Transcription Factor
  FOS            Fos Proto-Oncogene, AP-1 Transcription Factor Subunit
  LDLR           Low Density Lipoprotein Receptor
  TNFSF11        TNF Superfamily Member 11
  SOD1           Superoxide Dismutase 1
  TTC21B         Tetratricopeptide Repeat Domain 21B
  RAC1           Rac Family Small GTPase 1
  ANGPTL4        Angiopoietin Like 4
  SMAD7          SMAD Family Member 7
  MAPK1          Mitogen-Activated Protein Kinase 1
  MPO            Myeloperoxidase
  ACE2           Angiotensin I Converting Enzyme 2
  MYC            MYC Proto-Oncogene, BHLH Transcription Factor
  ABCB1          ATP Binding Cassette Subfamily B Member 1
  HGF            Hepatocyte Growth Factor
  B2M            Beta-2-Microglobulin
  MAPK3          Mitogen-Activated Protein Kinase 3
  ENG            Endoglin
  PPARA          Peroxisome Proliferator Activated Receptor Alpha
  BCL2           BCL2, Apoptosis Regulator
  HMOX1          Heme Oxygenase 1
  CCL5           C-C Motif Chemokine Ligand 5
  IL15           Interleukin 15
  HPX            Hemopexin
  ESR1           Estrogen Receptor 1
  EGF            Epidermal Growth Factor
  CASP3          Caspase 3
  NR3C1          Nuclear Receptor Subfamily 3 Group C Member 1
  NRP1           Neuropilin 1
  TNFRSF11A      TNF Receptor Superfamily Member 11a
  CD2            CD2 Molecule
  GREM1          Gremlin 1, DAN Family BMP Antagonist
  MIR30A         MicroRNA 30a
  CXCR4          C-X-C Motif Chemokine Receptor 4
  JAK3           Janus Kinase 3
  TLR3           Toll Like Receptor 3
  FTH1           Ferritin Heavy Chain 1
  NOTCH2         Notch 2
  SIRT1          Sirtuin 1
  EPAS1          Endothelial PAS Domain Protein 1
  GGT1           Gamma-Glutamyltransferase 1
  ABCA1          ATP Binding Cassette Subfamily A Member 1
  CASP9          Caspase 9
  NFATC1         Nuclear Factor Of Activated T Cells 1
  YAP1           Yes Associated Protein 1
  GFER           Growth Factor, Augmenter Of Liver Regeneration
  CEBPA          CCAAT Enhancer Binding Protein Alpha
  LIPC           Lipase C, Hepatic Type
  HSP90B1        Heat Shock Protein 90 Beta Family Member 1
  SMAD6          SMAD Family Member 6
  ATF3           Activating Transcription Factor 3
  PROM1          Prominin 1
  AGTR2          Angiotensin II Receptor Type 2
  LGALS1         Galectin 1
  NRP2           Neuropilin 2
  SP3            Sp3 Transcription Factor
  DDN            Dendrin
  CD24           CD24 Molecule
  MIR30D         MicroRNA 30d
  MET            MET Proto-Oncogene, Receptor Tyrosine Kinase
  PRKCD          Protein Kinase C Delta
  CTSD           Cathepsin D
  CASP8          Caspase 8
  FAS            Fas Cell Surface Death Receptor
  TF             Transferrin
  ALOX5          Arachidonate 5-Lipoxygenase
  KRT18          Keratin 18
  RELA           RELA Proto-Oncogene, NF-KB Subunit
  BDNF           Brain Derived Neurotrophic Factor
  CTLA4          Cytotoxic T-Lymphocyte Associated Protein 4
  LTA4H          Leukotriene A4 Hydrolase
  NLRP3          NLR Family Pyrin Domain Containing 3
  HSPA5          Heat Shock Protein Family A (Hsp70) Member 5
  HSPG2          Heparan Sulfate Proteoglycan 2
  CXCL12         C-X-C Motif Chemokine Ligand 12
  SPP1           Secreted Phosphoprotein 1
  TRPV5          Transient Receptor Potential Cation Channel Subfamily V Member 5
  COL4A6         Collagen Type IV Alpha 6 Chain
  PDGFD          Platelet Derived Growth Factor D
  IL13           Interleukin 13
  IL9            Interleukin 9
  HBEGF          Heparin Binding EGF Like Growth Factor
  LTC4S          Leukotriene C4 Synthase
  TRAF1          TNF Receptor Associated Factor 1
  WWC1           WW And C2 Domain Containing 1
  VASP           Vasodilator Stimulated Phosphoprotein
  EPO            Erythropoietin
  HHIP           Hedgehog Interacting Protein
  GNPTAB         N-Acetylglucosamine-1-Phosphate Transferase Subunits Alpha And Beta
  ADAM19         ADAM Metallopeptidase Domain 19
  CAPZA1         Capping Actin Protein Of Muscle Z-Line Subunit Alpha 1
  ATL1           Atlastin GTPase 1
  PFN2           Profilin 2
  PDLIM1         PDZ And LIM Domain 1
  STK16          Serine/Threonine Kinase 16
  IL7            Interleukin 7
  TRPC1          Transient Receptor Potential Cation Channel Subfamily C Member 1
  SNX9           Sorting Nexin 9
  UBD            Ubiquitin D
  EPB41L5        Erythrocyte Membrane Protein Band 4.1 Like 5
  PDLIM2         PDZ And LIM Domain 2
  ETV7           ETS Variant 7
  ACTL7A         Actin Like 7A
  MIR10A         MicroRNA 10a
  MIR135A1       MicroRNA 135a-1
  MIR135B        MicroRNA 135b
  MIR217         MicroRNA 217
  MIR378A        MicroRNA 378a
  MIR135A2       MicroRNA 135a-2
  MT-TL1         Mitochondrially Encoded TRNA Leucine 1 (UUA/G)
  HNP1           Hypertensive Nephropathy
  AGER           Advanced Glycosylation End-Product Specific Receptor
  GLA            Galactosidase Alpha
  CXCL8          C-X-C Motif Chemokine Ligand 8
  AKR1B1         Aldo-Keto Reductase Family 1 Member B
  JUN            Jun Proto-Oncogene, AP-1 Transcription Factor Subunit
  NOS3           Nitric Oxide Synthase 3
  COL4A2         Collagen Type IV Alpha 2 Chain
  KNG1           Kininogen 1
  MMP9           Matrix Metallopeptidase 9
  TGFBR2         Transforming Growth Factor Beta Receptor 2
  DES            Desmin
  PRKCB          Protein Kinase C Beta
  DCN            Decorin
  VCAM1          Vascular Cell Adhesion Molecule 1
  HRAS           HRas Proto-Oncogene, GTPase
  CASP1          Caspase 1
  IFNGR1         Interferon Gamma Receptor 1
  NR1H2          Nuclear Receptor Subfamily 1 Group H Member 2
  CFB            Complement Factor B
  ANTXR2         ANTXR Cell Adhesion Molecule 2
  MSR1           Macrophage Scavenger Receptor 1
  CASP4          Caspase 4
  HLA-DRB1       Major Histocompatibility Complex, Class II, DR Beta 1
  IL12A          Interleukin 12A
  COX5A          Cytochrome *C* Oxidase Subunit 5A
  HP             Haptoglobin
  PRTN3          Proteinase 3
  OLR1           Oxidized Low Density Lipoprotein Receptor 1
  HLA-DQB1       Major Histocompatibility Complex, Class II, DQ Beta 1
  EREG           Epiregulin
  DIAPH2         Diaphanous Related Formin 2
  AZGP1          Alpha-2-Glycoprotein 1, Zinc-Binding
  AREG           Amphiregulin
  PTAFR          Platelet Activating Factor Receptor
  TLE4           Transducin Like Enhancer Of Split 4
  IL12B          Interleukin 12B
  BPI            Bactericidal Permeability Increasing Protein
  SCGB1A1        Secretoglobin Family 1A Member 1
  IFNA1          Interferon Alpha 1
  SEMA4C         Semaphorin 4C
  ADCK2          AarF Domain Containing Kinase 2
  MIR196A2       MicroRNA 196a-2
  MIR490         MicroRNA 490
  SMAD4          SMAD Family Member 4
  EDNRA          Endothelin Receptor Type A
  PLAT           Plasminogen Activator, Tissue Type
  E2F1           E2F Transcription Factor 1
  ITIH4          Inter-Alpha-Trypsin Inhibitor Heavy Chain Family Member 4
  MIR21          MicroRNA 21
  MMP1           Matrix Metallopeptidase 1
  CAT            Catalase
  MAPK10         Mitogen-Activated Protein Kinase 10
  PARP1          Poly(ADP-Ribose) Polymerase 1
  RB1            RB Transcriptional Corepressor 1
  ESR2           Estrogen Receptor 2
  CD36           CD36 Molecule
  GDNF           Glial Cell Derived Neurotrophic Factor
  LEP            Leptin
  NPPA           Natriuretic Peptide A
  MBL2           Mannose Binding Lectin 2
  CST3           Cystatin C
  SEMA3A         Semaphorin 3A
  THBS1          Thrombospondin 1
  UMOD           Uromodulin
  SERPINB7       Serpin Family B Member 7
  AKT2           AKT Serine/Threonine Kinase 2
  NFKB1          Nuclear Factor Kappa B Subunit 1
  STAT3          Signal Transducer And Activator Of Transcription 3
  CDC42          Cell Division Cycle 42
  CYP3A4         Cytochrome P450 Family 3 Subfamily A Member 4
  NFKBIA         NFKB Inhibitor Alpha
  MAPK8          Mitogen-Activated Protein Kinase 8
  CD40           CD40 Molecule
  C3             Complement C3
  PLG            Plasminogen
  MMP7           Matrix Metallopeptidase 7
  PTK2B          Protein Tyrosine Kinase 2 Beta
  DDX58          DExD/H-Box Helicase 58
  COL4A1         Collagen Type IV Alpha 1 Chain
  PIK3CG         Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma
  MYH7           Myosin Heavy Chain 7
  IGF2           Insulin Like Growth Factor 2
  ECE1           Endothelin Converting Enzyme 1
  C5             Complement C5
  COL1A2         Collagen Type I Alpha 2 Chain
  PROS1          Protein S
  MYH6           Myosin Heavy Chain 6
  TNC            Tenascin C
  VCAN           Versican
  GFPT1          Glutamine--Fructose-6-Phosphate Transaminase 1
  EDN3           Endothelin 3
  CCR1           C-C Motif Chemokine Receptor 1
  ADIPOQ         Adiponectin, C1Q And Collagen Domain Containing
  TRIO           Trio Rho Guanine Nucleotide Exchange Factor
  FABP4          Fatty Acid Binding Protein 4
  CCR2           C-C Motif Chemokine Receptor 2
  CSF1           Colony Stimulating Factor 1
  BMP7           Bone Morphogenetic Protein 7
  S100A8         S100 Calcium Binding Protein A8
  MLXIPL         MLX Interacting Protein Like
  TNFRSF12A      TNF Receptor Superfamily Member 12A
  PLTP           Phospholipid Transfer Protein
  PDPN           Podoplanin
  NID1           Nidogen 1
  FMOD           Fibromodulin
  NES            Nestin
  SLC25A17       Solute Carrier Family 25 Member 17
  TNFSF12        TNF Superfamily Member 12
  USF2           Upstream Transcription Factor 2, C-Fos Interacting
  ZFYVE9         Zinc Finger FYVE-Type Containing 9
  PITRM1         Pitrilysin Metallopeptidase 1
  SMPDL3B        Sphingomyelin Phosphodiesterase Acid Like 3B
  CCN1           Cellular Communication Network Factor 1
  PDGFRA         Platelet Derived Growth Factor Receptor Alpha
  EGFR           Epidermal Growth Factor Receptor
  PDGFRB         Platelet Derived Growth Factor Receptor Beta
  JAK2           Janus Kinase 2
  KDR            Kinase Insert Domain Receptor
  MAP2K1         Mitogen-Activated Protein Kinase Kinase 1
  MAP2K2         Mitogen-Activated Protein Kinase Kinase 2
  INSR           Insulin Receptor
  AR             Androgen Receptor
  AKT3           AKT Serine/Threonine Kinase 3
  PIK3CA         Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha
  PTEN           Phosphatase And Tensin Homolog
  STAT1          Signal Transducer And Activator Of Transcription 1
  CDK5           Cyclin Dependent Kinase 5
  ADK            Adenosine Kinase
  MMP3           Matrix Metallopeptidase 3
  UCHL1          Ubiquitin C-Terminal Hydrolase L1
  CD4            CD4 Molecule
  CDKN2A         Cyclin Dependent Kinase Inhibitor 2A
  CTSB           Cathepsin B
  CASP7          Caspase 7
  ACVRL1         Activin A Receptor Like Type 1
  ADAM17         ADAM Metallopeptidase Domain 17
  PPIB           Peptidylprolyl Isomerase B
  HSPB1          Heat Shock Protein Family B (Small) Member 1
  YWHAE          Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon
  GATA3          GATA Binding Protein 3
  JAK1           Janus Kinase 1
  HDAC3          Histone Deacetylase 3
  NTRK1          Neurotrophic Receptor Tyrosine Kinase 1
  NOS1           Nitric Oxide Synthase 1
  CCNE1          Cyclin E1
  ACACA          Acetyl-CoA Carboxylase Alpha
  CAV1           Caveolin 1
  PRKCZ          Protein Kinase C Zeta
  SGK1           Serum/Glucocorticoid Regulated Kinase 1
  NR3C2          Nuclear Receptor Subfamily 3 Group C Member 2
  SLC5A1         Solute Carrier Family 5 Member 1
  TFRC           Transferrin Receptor
  TGFB2          Transforming Growth Factor Beta 2
  VWF            Von Willebrand Factor
  FOXO1          Forkhead Box O1
  CYP3A5         Cytochrome P450 Family 3 Subfamily A Member 5
  FASLG          Fas Ligand
  CCR5           C-C Motif Chemokine Receptor 5 (Gene/Pseudogene)
  CES1           Carboxylesterase 1
  CNR1           Cannabinoid Receptor 1
  PPARD          Peroxisome Proliferator Activated Receptor Delta
  SELP           Selectin P
  MMP10          Matrix Metallopeptidase 10
  NR1H3          Nuclear Receptor Subfamily 1 Group H Member 3
  MS4A1          Membrane Spanning 4-Domains A1
  SPHK1          Sphingosine Kinase 1
  LRP1           LDL Receptor Related Protein 1
  HDAC9          Histone Deacetylase 9
  TGFA           Transforming Growth Factor Alpha
  TRAF3          TNF Receptor Associated Factor 3
  TRAF6          TNF Receptor Associated Factor 6
  TSHR           Thyroid Stimulating Hormone Receptor
  ADORA2B        Adenosine A2b Receptor
  BID            BH3 Interacting Domain Death Agonist
  CA8            Carbonic Anhydrase 8
  CDK5R1         Cyclin Dependent Kinase 5 Regulatory Subunit 1
  CFH            Complement Factor H
  CDK1           Cyclin Dependent Kinase 1
  ANXA5          Annexin A5
  ANG            Angiogenin
  ITGB6          Integrin Subunit Beta 6
  LNPEP          Leucyl And Cystinyl Aminopeptidase
  SERPINH1       Serpin Family H Member 1
  S100B          S100 Calcium Binding Protein B
  TBX3           T-Box 3
  PXN            Paxillin
  TGIF1          TGFB Induced Factor Homeobox 1
  TNFSF13B       TNF Superfamily Member 13b
  ZYX            Zyxin
  GH1            Growth Hormone 1
  CX3CR1         C-X3-C Motif Chemokine Receptor 1
  LGALS3         Galectin 3
  HIPK2          Homeodomain Interacting Protein Kinase 2
  STMN1          Stathmin 1
  HPSE           Heparanase
  EGR1           Early Growth Response 1
  CD34           CD34 Molecule
  EEF1A1         Eukaryotic Translation Elongation Factor 1 Alpha 1
  CTNS           Cystinosin, Lysosomal Cystine Transporter
  BDKRB2         Bradykinin Receptor B2
  HDAC7          Histone Deacetylase 7
  IQGAP1         IQ Motif Containing GTPase Activating Protein 1
  SALL1          Spalt Like Transcription Factor 1
  MPZ            Myelin Protein Zero
  MEFV           MEFV, Pyrin Innate Immunity Regulator
  TAT            Tyrosine Aminotransferase
  SPI1           Spi-1 Proto-Oncogene
  RAB3A          RAB3A, Member RAS Oncogene Family
  USF1           Upstream Transcription Factor 1
  FOXO3          Forkhead Box O3
  DDAH2          Dimethylarginine Dimethylaminohydrolase 2
  FCGR3B         Fc Fragment Of IgG Receptor IIIb
  IL17A          Interleukin 17A
  P2RX4          Purinergic Receptor P2X 4
  PLXNA1         Plexin A1
  TG             Thyroglobulin
  TNFRSF6B       TNF Receptor Superfamily Member 6b
  CSRP3          Cysteine And Glycine Rich Protein 3
  ACTC1          Actin, Alpha, Cardiac Muscle 1
  C4A            Complement C4A (Rodgers Blood Group)
  TAGLN          Transgelin
  ID1            Inhibitor Of DNA Binding 1, HLH Protein
  CCL4           C-C Motif Chemokine Ligand 4
  FCAR           Fc Fragment Of IgA Receptor
  CAMP           Cathelicidin Antimicrobial Peptide
  COL8A2         Collagen Type VIII Alpha 2 Chain
  ST3GAL4        ST3 Beta-Galactoside Alpha-2,3-Sialyltransferase 4
  IL1RL1         Interleukin 1 Receptor Like 1
  WASL           Wiskott-Aldrich Syndrome Like
  CHIA           Chitinase, Acidic
  BPHL           Biphenyl Hydrolase Like
  KLF15          Kruppel Like Factor 15
  PLA2R1         Phospholipase A2 Receptor 1
  RHOD           Ras Homolog Family Member D
  SCAP           SREBF Chaperone
  PDLIM5         PDZ And LIM Domain 5
  RPH3A          Rabphilin 3A
  HIST1H1B       Histone Cluster 1 H1 Family Member B
  CCL3           C-C Motif Chemokine Ligand 3
  COL8A1         Collagen Type VIII Alpha 1 Chain
  PECAM1         Platelet And Endothelial Cell Adhesion Molecule 1
  P3H1           Prolyl 3-Hydroxylase 1
  NUP133         Nucleoporin 133
  SNF8           SNF8, ESCRT-II Complex Subunit
  TSLP           Thymic Stromal Lymphopoietin
  ACTN3          Actinin Alpha 3 (Gene/Pseudogene)
  LECT2          Leukocyte Cell Derived Chemotaxin 2
  WDR19          WD Repeat Domain 19
  CSN1S1         Casein Alpha S1
  GOLIM4         Golgi Integral Membrane Protein 4
  MPV17L         MPV17 Mitochondrial Inner Membrane Protein Like
  WTIP           WT1 Interacting Protein
  HIST2H3C       Histone Cluster 2 H3 Family Member C
  KRBOX4         KRAB Box Domain Containing 4
  MIR216A        MicroRNA 216a
  MBL3P          Mannose-Binding Lectin Family Member 3, Pseudogene

###### Information for target genes of tripterygium from TCMSP database

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Mol Id      Gene Name   Mol name
  ----------- ----------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  MOL000296   PGR         hederagenin

  MOL000296   NCOA2       hederagenin

  MOL000296   CHRM3       hederagenin

  MOL000296   CHRM1       hederagenin

  MOL000296   CHRM2       hederagenin

  MOL000296   ADRA1B      hederagenin

  MOL000296   GABRA1      hederagenin

  MOL000296   GRIA2       hederagenin

  MOL000296   ADH1B       hederagenin

  MOL000296   ADH1C       hederagenin

  MOL000296   LYZ         hederagenin

  MOL000296   PTGS1       hederagenin

  MOL000296   SCN5A       hederagenin

  MOL000296   PTGS2       hederagenin

  MOL000296   RXRA        hederagenin

  MOL000296   SLC6A2      hederagenin

  MOL003182   KCNH2       (+)-Medioresinol di-O-beta-D-glucopyranoside_qt

  MOL003182   SCN5A       (+)-Medioresinol di-O-beta-D-glucopyranoside_qt

  MOL003182   PTGS2       (+)-Medioresinol di-O-beta-D-glucopyranoside_qt

  MOL003182   F7          (+)-Medioresinol di-O-beta-D-glucopyranoside_qt

  MOL003184   PTGS1       81827-74-9

  MOL003184   CHRM3       81827-74-9

  MOL003184   KCNH2       81827-74-9

  MOL003184   CHRM1       81827-74-9

  MOL003184   SCN5A       81827-74-9

  MOL003184   CHRM5       81827-74-9

  MOL003184   PTGS2       81827-74-9

  MOL003184   CHRM4       81827-74-9

  MOL003184   OPRD1       81827-74-9

  MOL003184   PGR         81827-74-9

  MOL003184   CHRM2       81827-74-9

  MOL003184   ADRA1B      81827-74-9

  MOL003184   ADRB2       81827-74-9

  MOL003184   OPRM1       81827-74-9

  MOL003184   NCOA2       81827-74-9

  MOL003184   NCOA1       81827-74-9

  MOL003185   CHRM3       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a\
                          -dimethyl-4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   CHRM1       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl\
                          -4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   PTGS2       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl\
                          -4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   OPRD1       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl\
                          -4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   ADRA1A      (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   ADRA1B      (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   ADRA1D      (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   OPRM1       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   NR3C1       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   NCOA2       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   NCOA1       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   SCN5A       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   CHRM2       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003185   ADRB2       (1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-\
                          4,9,10,10a-tetrahydro-3H-phenanthren-2-one

  MOL003187   RELA        triptolide

  MOL003187   STAT3       triptolide

  MOL003187   VEGFA       triptolide

  MOL003187   BCL2        triptolide

  MOL003187   FOS         triptolide

  MOL003187   CDKN1A      triptolide

  MOL003187   PLAU        triptolide

  MOL003187   TNFSF15     triptolide

  MOL003187   JUN         triptolide

  MOL003187   CASP3       triptolide

  MOL003187   TP63        triptolide

  MOL003187   MAPK8       triptolide

  MOL003187   PTGS2       triptolide

  MOL003187   STAT1       triptolide

  MOL003187   CXCL8       triptolide

  MOL003187   MCL1        triptolide

  MOL003187   IL2         triptolide

  MOL003187   IFNG        triptolide

  MOL003187   IL4         triptolide

  MOL003187   CD80        triptolide

  MOL003187   CD86        triptolide

  MOL003187   CXCR4       triptolide

  MOL003187   BIRC3       triptolide

  MOL003187   CD274       triptolide

  MOL003187   IL23A       triptolide

  MOL003187   CCR7        triptolide

  MOL003187   CD1A        triptolide

  MOL003187   CD40        triptolide

  MOL003187   CD14        triptolide

  MOL003187   C3          triptolide

  MOL003187   VTCN1       triptolide

  MOL003196   CHRM3       Tryptophenolide

  MOL003196   KCNH2       Tryptophenolide

  MOL003196   CHRM1       Tryptophenolide

  MOL003196   SCN5A       Tryptophenolide

  MOL003196   CHRM5       Tryptophenolide

  MOL003196   PTGS2       Tryptophenolide

  MOL003196   RXRA        Tryptophenolide

  MOL003196   OPRD1       Tryptophenolide

  MOL003196   ADRA1A      Tryptophenolide

  MOL003196   PGR         Tryptophenolide

  MOL003196   CHRM2       Tryptophenolide

  MOL003196   ADRA1B      Tryptophenolide

  MOL003196   ADRB2       Tryptophenolide

  MOL003196   ADRA1D      Tryptophenolide

  MOL003196   OPRM1       Tryptophenolide

  MOL003196   NCOA2       Tryptophenolide

  MOL003196   NCOA1       Tryptophenolide

  MOL003199   NOS2        5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   PTGS1       5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   KCNH2       5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   ESR1        5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   AR          5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   SCN5A       5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   PPARG       5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   PTGS2       5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   F7          5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   KDR         5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   PYGM        5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003199   PRSS1       5,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin

  MOL003209   KCNH2       Celallocinnine

  MOL003209   SCN5A       Celallocinnine

  MOL003217   NOS2        Isoxanthohumol

  MOL003217   KCNH2       Isoxanthohumol

  MOL003217   ESR1        Isoxanthohumol

  MOL003217   SCN5A       Isoxanthohumol

  MOL003217   PTGS2       Isoxanthohumol

  MOL003217   KDR         Isoxanthohumol

  MOL003217   ADRA1B      Isoxanthohumol

  MOL003217   ADRB2       Isoxanthohumol

  MOL003217   NCOA2       Isoxanthohumol

  MOL003217   NCOA1       Isoxanthohumol

  MOL003217   PTGS1       Isoxanthohumol

  MOL003217   PPARD       Isoxanthohumol

  MOL003224   NR3C2       Tripdiotolnide

  MOL003225   NR3C2       Hypodiolide A

  MOL003225   NR3C1       Hypodiolide A

  MOL003229   CHRM3       Triptinin B

  MOL003229   KCNH2       Triptinin B

  MOL003229   CHRM1       Triptinin B

  MOL003229   SCN5A       Triptinin B

  MOL003229   CHRM5       Triptinin B

  MOL003229   PTGS2       Triptinin B

  MOL003229   RXRA        Triptinin B

  MOL003229   ADRA1A      Triptinin B

  MOL003229   PGR         Triptinin B

  MOL003229   CHRM2       Triptinin B

  MOL003229   ADRA1B      Triptinin B

  MOL003229   ADRB2       Triptinin B

  MOL003229   ADRA1D      Triptinin B

  MOL003229   OPRM1       Triptinin B

  MOL003229   NR3C1       Triptinin B

  MOL003229   RXRB        Triptinin B

  MOL003229   NCOA2       Triptinin B

  MOL003229   NCOA1       Triptinin B

  MOL003231   PTGS1       Triptoditerpenic acid B

  MOL003231   CHRM3       Triptoditerpenic acid B

  MOL003231   KCNH2       Triptoditerpenic acid B

  MOL003231   CHRM1       Triptoditerpenic acid B

  MOL003231   SCN5A       Triptoditerpenic acid B

  MOL003231   CHRM5       Triptoditerpenic acid B

  MOL003231   PTGS2       Triptoditerpenic acid B

  MOL003231   CHRM4       Triptoditerpenic acid B

  MOL003231   RXRA        Triptoditerpenic acid B

  MOL003231   OPRD1       Triptoditerpenic acid B

  MOL003231   ADRA1A      Triptoditerpenic acid B

  MOL003231   PGR         Triptoditerpenic acid B

  MOL003231   CHRM2       Triptoditerpenic acid B

  MOL003231   ADRA1B      Triptoditerpenic acid B

  MOL003231   ADRB2       Triptoditerpenic acid B

  MOL003231   ADRA1D      Triptoditerpenic acid B

  MOL003231   OPRM1       Triptoditerpenic acid B

  MOL003231   NR3C1       Triptoditerpenic acid B

  MOL003231   RXRB        Triptoditerpenic acid B

  MOL003231   NCOA2       Triptoditerpenic acid B

  MOL003231   NCOA1       Triptoditerpenic acid B

  MOL003245   CHRM3       Triptonoditerpenic acid

  MOL003245   KCNH2       Triptonoditerpenic acid

  MOL003245   CHRM1       Triptonoditerpenic acid

  MOL003245   SCN5A       Triptonoditerpenic acid

  MOL003245   PTGS2       Triptonoditerpenic acid

  MOL003245   OPRD1       Triptonoditerpenic acid

  MOL003245   ADRA1B      Triptonoditerpenic acid

  MOL003245   ADRB2       Triptonoditerpenic acid

  MOL003245   NCOA2       Triptonoditerpenic acid

  MOL003245   NCOA1       Triptonoditerpenic acid

  MOL003248   PTGS1       Triptonoterpene

  MOL003248   CHRM3       Triptonoterpene

  MOL003248   CHRM1       Triptonoterpene

  MOL003248   SCN5A       Triptonoterpene

  MOL003248   PTGS2       Triptonoterpene

  MOL003248   RXRA        Triptonoterpene

  MOL003248   ACHE        Triptonoterpene

  MOL003248   ADRA1A      Triptonoterpene

  MOL003248   PGR         Triptonoterpene

  MOL003248   CHRM2       Triptonoterpene

  MOL003248   ADRA1B      Triptonoterpene

  MOL003248   ADRB2       Triptonoterpene

  MOL003248   ADRA1D      Triptonoterpene

  MOL003248   OPRM1       Triptonoterpene

  MOL003248   NR3C1       Triptonoterpene

  MOL003248   NCOA2       Triptonoterpene

  MOL003248   NCOA1       Triptonoterpene

  MOL003266   PGR         21-Hydroxy-30-norhopan-22-one

  MOL003280   CHRM3       TRIPTONOLIDE

  MOL003280   CHRM1       TRIPTONOLIDE

  MOL003280   SCN5A       TRIPTONOLIDE

  MOL003280   CHRM5       TRIPTONOLIDE

  MOL003280   PTGS2       TRIPTONOLIDE

  MOL003280   OPRD1       TRIPTONOLIDE

  MOL003280   ADRA1A      TRIPTONOLIDE

  MOL003280   PGR         TRIPTONOLIDE

  MOL003280   CHRM2       TRIPTONOLIDE

  MOL003280   ADRB2       TRIPTONOLIDE

  MOL003280   OPRM1       TRIPTONOLIDE

  MOL003280   NCOA2       TRIPTONOLIDE

  MOL003280   NCOA1       TRIPTONOLIDE

  MOL000358   PGR         beta-sitosterol

  MOL000358   NCOA2       beta-sitosterol

  MOL000358   PTGS1       beta-sitosterol

  MOL000358   PTGS2       beta-sitosterol

  MOL000358   KCNH2       beta-sitosterol

  MOL000358   CHRM3       beta-sitosterol

  MOL000358   CHRM1       beta-sitosterol

  MOL000358   SCN5A       beta-sitosterol

  MOL000358   CHRM4       beta-sitosterol

  MOL000358   ADRA1A      beta-sitosterol

  MOL000358   CHRM2       beta-sitosterol

  MOL000358   ADRA1B      beta-sitosterol

  MOL000358   ADRB2       beta-sitosterol

  MOL000358   CHRNA2      beta-sitosterol

  MOL000358   SLC6A4      beta-sitosterol

  MOL000358   OPRM1       beta-sitosterol

  MOL000358   GABRA1      beta-sitosterol

  MOL000358   BCL2        beta-sitosterol

  MOL000358   BAX         beta-sitosterol

  MOL000358   CASP9       beta-sitosterol

  MOL000358   JUN         beta-sitosterol

  MOL000358   CASP3       beta-sitosterol

  MOL000358   CASP8       beta-sitosterol

  MOL000358   PRKCA       beta-sitosterol

  MOL000358   PON1        beta-sitosterol

  MOL000358   MAP2        beta-sitosterol

  MOL000211   PGR         Mairin

  MOL000422   NOS2        kaempferol

  MOL000422   PTGS1       kaempferol

  MOL000422   AR          kaempferol

  MOL000422   PPARG       kaempferol

  MOL000422   PTGS2       kaempferol

  MOL000422   NCOA2       kaempferol

  MOL000422   PRSS1       kaempferol

  MOL000422   PGR         kaempferol

  MOL000422   CHRM1       kaempferol

  MOL000422   ACHE        kaempferol

  MOL000422   SLC6A2      kaempferol

  MOL000422   CHRM2       kaempferol

  MOL000422   ADRA1B      kaempferol

  MOL000422   GABRA1      kaempferol

  MOL000422   F7          kaempferol

  MOL000422   RELA        kaempferol

  MOL000422   IKBKB       kaempferol

  MOL000422   AKT1        kaempferol

  MOL000422   BCL2        kaempferol

  MOL000422   BAX         kaempferol

  MOL000422   TNFSF15     kaempferol

  MOL000422   JUN         kaempferol

  MOL000422   AHSA1       kaempferol

  MOL000422   CASP3       kaempferol

  MOL000422   MAPK8       kaempferol

  MOL000422   MMP1        kaempferol

  MOL000422   STAT1       kaempferol

  MOL000422   PPARG       kaempferol

  MOL000422   HMOX1       kaempferol

  MOL000422   CYP3A4      kaempferol

  MOL000422   CYP1A2      kaempferol

  MOL000422   CYP1A1      kaempferol

  MOL000422   ICAM1       kaempferol

  MOL000422   SELE        kaempferol

  MOL000422   VCAM1       kaempferol

  MOL000422   NR1I2       kaempferol

  MOL000422   CYP1B1      kaempferol

  MOL000422   ALOX5       kaempferol

  MOL000422   HAS2        kaempferol

  MOL000422   GSTP1       kaempferol

  MOL000422   AHR         kaempferol

  MOL000422   PSMD3       kaempferol

  MOL000422   SLC2A4      kaempferol

  MOL000422   NR1I3       kaempferol

  MOL000422   INSR        kaempferol

  MOL000422   DIO1        kaempferol

  MOL000422   PPP3CA      kaempferol

  MOL000422   GSTM1       kaempferol

  MOL000422   GSTM2       kaempferol

  MOL000422   AKR1C3      kaempferol

  MOL000422   SLPI        kaempferol

  MOL000449   PGR         Stigmasterol

  MOL000449   NR3C2       Stigmasterol

  MOL000449   NCOA2       Stigmasterol

  MOL000449   ADH1C       Stigmasterol

  MOL000449   RXRA        Stigmasterol

  MOL000449   NCOA1       Stigmasterol

  MOL000449   PTGS1       Stigmasterol

  MOL000449   PTGS2       Stigmasterol

  MOL000449   ADRA2A      Stigmasterol

  MOL000449   SLC6A2      Stigmasterol

  MOL000449   SLC6A3      Stigmasterol

  MOL000449   ADRB2       Stigmasterol

  MOL000449   AKR1B1      Stigmasterol

  MOL000449   PLAU        Stigmasterol

  MOL000449   LTA4H       Stigmasterol

  MOL000449   MAOB        Stigmasterol

  MOL000449   MAOA        Stigmasterol

  MOL000449   CTRB1       Stigmasterol

  MOL000449   CHRM3       Stigmasterol

  MOL000449   CHRM1       Stigmasterol

  MOL000449   ADRB1       Stigmasterol

  MOL000449   SCN5A       Stigmasterol

  MOL000449   ADRA1A      Stigmasterol

  MOL000449   CHRM2       Stigmasterol

  MOL000449   ADRA1B      Stigmasterol

  MOL000449   GABRA1      Stigmasterol

  MOL002058   KCNH2       40957-99-1

  MOL002058   SCN5A       40957-99-1

  MOL002058   PTGS2       40957-99-1

  MOL002058   PTGS1       40957-99-1

  MOL002058   NCOA2       40957-99-1

  MOL002058   F7          40957-99-1

  MOL003283   ESR1        (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   AR          (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   PPARG       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   PTGS2       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   F7          (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   ADRB2       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   ESR2        (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   MAPK14      (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   GSK3B       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   CHEK1       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   NCOA2       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   SCN5A       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   CCNA2       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL003283   PTGS1       (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol

  MOL004443   PTGS1       Zhebeiresinol

  MOL004443   SCN5A       Zhebeiresinol

  MOL004443   PTGS2       Zhebeiresinol

  MOL004443   RXRA        Zhebeiresinol

  MOL004443   ADRB2       Zhebeiresinol

  MOL004443   GABRA1      Zhebeiresinol

  MOL005828   NOS2        nobiletin

  MOL005828   PTGS1       nobiletin

  MOL005828   KCNH2       nobiletin

  MOL005828   ESR1        nobiletin

  MOL005828   AR          nobiletin

  MOL005828   PPARG       nobiletin

  MOL005828   PTGS2       nobiletin

  MOL005828   F7          nobiletin

  MOL005828   ESR2        nobiletin

  MOL005828   CHEK1       nobiletin

  MOL005828   PRSS1       nobiletin

  MOL005828   NCOA2       nobiletin

  MOL005828   GSK3B       nobiletin

  MOL005828   SCN5A       nobiletin

  MOL005828   BCL2        nobiletin

  MOL005828   BAX         nobiletin

  MOL005828   CASP9       nobiletin

  MOL005828   MMP9        nobiletin

  MOL005828   JUN         nobiletin

  MOL005828   TP63        nobiletin

  MOL005828   MAPK8       nobiletin

  MOL005828   TIMP1       nobiletin

  MOL005828   PPARG       nobiletin

  MOL005828   CREB1       nobiletin

  MOL005828   PLA2G4A     nobiletin

  MOL005828   CD163       nobiletin

  MOL005828   EPHB2       nobiletin

  MOL007415   KCNH2       \[(2S)-2-\[\[(2S)-2-(benzoylamino)-3-phenylpropanoyl\]amino\]-3-phenylpropyl\] acetate

  MOL007415   PTGS2       \[(2S)-2-\[\[(2S)-2-(benzoylamino)-3-phenylpropanoyl\]amino\]-3-phenylpropyl\] acetate

  MOL007415   PRSS1       \[(2S)-2-\[\[(2S)-2-(benzoylamino)-3-phenylpropanoyl\]amino\]-3-phenylpropyl\] acetate

  MOL007535   PGR         (5S,8S,9S,10R,13R,14S,17R)-17-\[(1R,4R)-4-ethyl-1,5-dimethylhexyl\]-10,13-dimethyl-2,4,5,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta\[a\]phenanthrene-3,6-dione

  MOL009386   KCNH2       3,3′-bis-(3,4-dihydro-4-hydroxy-6-methoxy)-2H-1-benzopyran

  MOL009386   ESR1        3,3′-bis-(3,4-dihydro-4-hydroxy-6-methoxy)-2H-1-benzopyran

  MOL009386   PTGS2       3,3′-bis-(3,4-dihydro-4-hydroxy-6-methoxy)-2H-1-benzopyran

  MOL009386   ADRB2       3,3′-bis-(3,4-dihydro-4-hydroxy-6-methoxy)-2H-1-benzopyran

  MOL009386   CCNA2       3,3′-bis-(3,4-dihydro-4-hydroxy-6-methoxy)-2H-1-benzopyran
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Enrichment analysis of GO and KEGG {#sec3-3}
----------------------------------

Forty-seven overlapping targets were screened for further investigation using the DAVID (htTPLs://david.ncifcrf.gov/) online tool. GO annotation results showed that the top 30 biological processes (BP) included cell apoptosis, proliferation of cells, positive signal transduction regulation, extracellular stimulus response, and cell death ([Figure 2](#F2){ref-type="fig"}A). The results of KEGG enrichment analysis showed that the 47 overlapping targets were markedly enriched within 32 pathways, including the p53 signal transduction pathway, apoptosis, and the JAK-STAT signal transduction pathway ([Figure 2](#F2){ref-type="fig"}B). *IL4* was mainly enriched in BP terms, including programmed cell death regulation, endogenous stimulus response, apoptosis regulation, positive cell proliferation regulation, and positive nitrogen compound metabolic process regulation. Based on the KEGG enrichment results, IL4 participated in the T-cell receptor signal transduction pathway, allograft rejection, intestinal IgA production immunologic network, the JAK-STAT signal transduction pathway, autoimmune thyroid disease, the Fc epsilon RI signal transduction pathway, and the interaction between cytokines and cytokine receptors.

![Analysis of GO and KEGG Enrichment\
(**A**) 47 overlapped genes were analysis by GO annotation, which showed that the top 30 biological processes (BP). (**B**) 47 overlapped genes was analysis by KEGG, which enriched in 32 pathways.](bsr-40-bsr20192920-g2){#F2}

TPL alleviated kidney injury by inhibiting cell apoptosis in FSGS rats, and IL4 was up-regulated in kidney tissues of FSGS rats {#sec3-4}
-------------------------------------------------------------------------------------------------------------------------------

FSGS rat models were established using external jugular vein cannulation; subsequently, the levels of BUN, 24-h urine protein, Scr, ALB, and TC were determined. Our results showed that the BUN, 24-h urine protein, TC, and Scr levels in FSGS animals were evidently decreased, while the ALB levels were significantly increased after the FSGS rats were administered TPL gavage (at 80 or 160 μg/(kg·d)) ([Figure 3](#F3){ref-type="fig"}A--E). HE staining results showed that TPL significantly decreased the glomerulosclerosis index (GSI) in FSGS rats ([Figure 3](#F3){ref-type="fig"}F,G). The apoptosis level was determined by TUNEL assay in the kidney tissues of FSGS rats. We found that FSGS promoted apoptosis in kidney tissues. However, TPL treatment suppressed the apoptosis of cells within the renal tissues of FSGS rats ([Figure 4](#F4){ref-type="fig"}A,B). Therefore, we further detected the protein levels of IL4, nephrin, and podocin and the phosphorylation level of Stat6 using Western blotting. According to our results, TPL treatment decreased IL4 protein levels and stat6 activation, and increased the protein levels of nephrin and podocin in FSGS rats ([Figure 4](#F4){ref-type="fig"}C--G).

![TPL alleviated kidney injure in FSGS rats\
FSGS rat models were establised by using external jugular vein cannulation, (**A**) 24 h urine protein, (**B**) BUN, (**C**) Scr, (**D**) TC and (**E**) ALB levels were detected; (**F**) TPL could significantly decrease glomerulosclerosis index (GSI) of FSGS rats; (**G**) The pathomorphology of kidney in FSGS rats was showed by HE staining. Data are presented as the mean ± standard deviation. *^a^P*\<0.05 versus Sham group, *^b^P*\<0.05 versus FSGS group, and *^c^P*\<0.05 versus TPL(80)+FSGS group.](bsr-40-bsr20192920-g3){#F3}

![TPL reduced cell apoptosis in FSGS rats\
FSGS rat models were established by using external jugular vein cannulation. (**A** and **B**) Apoptosis level was determined by TUNEL assay in kidney tissues of FSGS rats. (**C**) The protein levels of IL4, nephrin and podocin, and phosphorylation level of Stat6 by Western blotting analysis. (**D--G**) Histogram showed the statistical value. GAPDH was used as a load control. Data are presented as the mean ± standard deviation. *^a^P*\<0.05 versus Sham group, *^b^P*\<0.05 versus FSGS group, and *^c^P*\<0.05 versus TPL(80)+FSGS group.](bsr-40-bsr20192920-g4){#F4}

TPL reversed the function of IL4 overexpression, promoting cell apoptosis {#sec3-5}
-------------------------------------------------------------------------

According to the results, 0--80 μmol/ml TPL had no influence on cell viability and apoptosis ([Figure 5](#F5){ref-type="fig"}A--C). Western blotting results showed that 0--80 μmol/ml TPL minimally affected IL4, nephrin, and podocin expression and stat6 activation ([Figure 5](#F5){ref-type="fig"}D). However, IL4 overexpression inhibited the viability and promoted apoptosis of podocytes. TPL inhibited IL4 overexpression-mediated cell apoptosis ([Figure 6](#F6){ref-type="fig"}A--C). Furthermore, TPL decreased IL4 protein levels, increased nephrin and podocin protein levels, and inhibited the phosphorylation of Stat6 in podocytes ([Figure 6](#F6){ref-type="fig"}D).

![TPL has no influence on the cell viability and apoptosis\
(**A**) 0--80 μmol/ml of TPL little effected the viability of podocytes by CCK8 assay. (**B** and **C**) 0--80 μmol/ml of TPL little affected the apoptosis level of podocytes by flow cytometry assay. (**D**) The protein levels of IL4, nephrin and podocin, and phosphorylation level of Stat6 by Western blotting analysis. GAPDH was used as a load control. Data are presented as the mean ± standard deviation. *^a^P*\<0.05 versus Sham group, *^b^P*\<0.05 versus FSGS group, and *^c^P*\<0.05 versus TPL(80)+FSGS group.](bsr-40-bsr20192920-g5){#F5}

![TPL reversed the function of IL4 overexpression promoting cell apoptosis\
(**A**) IL4 protein and mRNA levels were detected by Western blot and RT-PCR assays. (**B**) The viability of podocytes by CCK8 assay in cell with IL4. (**C**) The apoptosis level of podocytes by flow cytometry assay in cell with IL4. (**D**) The protein levels of nephrin and podocin, and phosphorylation level of Stat6 by Western blotting analysis. GAPDH was used as a load control. Data are presented as the mean ± standard deviation. *^a^P*\<0.05 versus vector group, and *^b^P*\<0.05 versus IL4 group.](bsr-40-bsr20192920-g6){#F6}

Discussion {#sec4}
==========

The occurrence of FSGS is related to a variety of mechanisms. Podocyte injury is the central link of FSGS \[[@B16],[@B17]\]. Glomerular sclerosis is the final pathological change in FSGS caused by the excessive accumulation of the glomerular extracellular matrix (ECM). Podocytes are an important part of the glomerulus and are the final barriers that block the filtration of plasma macromolecules. Apoptosis, fusion, and shedding of podocytes induced the occurrence and development of FSGS. TPL has been reported to have a protective effect on kidney damage \[[@B18]\]. Therefore, we constructed the Disease--Target--Compound network in the present study through the TCM network pharmacology to confirm the relationship between TPL and FSGS. It was further confirmed by constructing a PPT network that *IL4* was a target gene of TPL and FSGS. According to KEGG and GO enrichment analyses, *IL4* was closely related to apoptosis and was enriched in the JAK-STAT signal pathway. Thus, we proposed two hypotheses: (1) TPL can protect against FSGS kidney injury by inhibiting apoptosis; (2) The protective effect of TPL on FSGS-induced kidney damage may be achieved by targeting IL4.

IL-4 is an anti-inflammatory factor that belongs to the interleukin family \[[@B19]\]. It has been reported that IL4 can inhibit apoptosis of liver cancer cells, and blockage of the IL4/IL4R/STAT6 axis can promote apoptosis of Hodgkin lymphoma cells \[[@B20]\]. However, IL4 may also be involved in the disease as a pro-inflammatory factor \[[@B21]\]. The expression level of IL4 is high in kidney tissue with acute kidney injury \[[@B22]\]. Therefore, the effect of IL4 on FSGS should be more extensively investigated. IL4 activates stat6 by acting on the JAK-STAT signal pathway. Our results demonstrated that IL4 expression and the phosphorylation level of stat6 were up-regulated in kidney tissues of FSGS rats. This suggests that the IL/STAT6 signaling pathway is aberrantly activated in FSGS. TPL reduced apoptosis in the kidney tissue of FSGS rats while significantly inhibiting the expression of IL4 and the activation of stat6.

Nephrin and podocin are podocyte proteins that have been widely used to identify kidney injury \[[@B23],[@B24]\]. It has been reported that podocin and nephrin levels were down-regulated in a kidney injury model to promote podocyte apoptosis, thereby aggravating kidney damage. Podocin and nephrin expression levels were remarkably down-regulated in the kidney tissue of FSGS rats. Similarly, TPL could upgrade the podocin and nephrin expression levels. This indicated that TPL attenuated glomerular sclerosis in FSGS rats by reducing podocyte apoptosis. To further investigate the mechanism of action of TPL on renal protection in FSGS rats, we carried out a study at the cellular level.

First, we need to investigate if 0--80 µmol/ml of TPL is toxic to podocyte. The functional experiment proved that TPL at low concentrations did not affect cell activity; cell apoptosis; the expression of IL4, nephrin, and podocin; and the activation of stat6, which excluded the threat of TPL for cells. The results showed that a high expression of IL4 inhibited cell viability, promoted apoptosis, increased phosphorylation of stat3, and inhibited the expression of nephrin and podocin. This suggested that a high expression of IL4 promoted apoptosis and aggravated glomerular sclerosis. TPL can reverse IL4-mediated podocyte apoptosis and reduce glomerular sclerosis.

In conclusion, up-regulation of IL4 in kidney tissue of FSGS rats activated stat6 and promoted podocyte apoptosis to aggravate glomerular sclerosis. TPL can alleviate glomerular sclerosis in FSGS rats by inhibiting the activation of the IL4/stat6 signaling pathway and podocyte apoptosis. This finding can offer a theoretical foundation for the application of TPL in treating FSGS.
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GO
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